OpenAI invests in startup aiming to prevent AI-enabled bioweapons
OpenAI is investing in Red Queen Bio, a startup focused on blocking bad actors from creating biological weapons powered by AI. OpenAI was the lead investor in the startup's $15-million seed round. The investment is part of its broader effort to back startups that aim to mitigate the risks posed by AI, as it recently backed biosecurity software startup Valthos.